| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $280.3M | +73.2% |
| SG&A Expense | $87.6M | +50.4% |
| Operating Income | -$367.8M | -67.1% |
| Interest Expense | $3.9M | — |
| Pre-tax Income | -$351.4M | -55.9% |
| Income Tax | $160K | — |
| Net Income | -$351.5M | -56.0% |
| EPS (Basic) | -$2.32 | -40.6% |
| EPS (Diluted) | -$2.32 | -40.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $136.5M | -29.3% |
| Current Assets | $905.7M | +56.7% |
| Total Assets | $1.02B | +47.7% |
| Current Liabilities | $72.6M | +70.6% |
| Long-term Debt | $388.1M | — |
| Total Liabilities | $496.6M | +350.7% |
| Stockholders' Equity | $521.2M | -9.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$293.2M | -64.2% |
| Capital Expenditures | $4.0M | -62.4% |
| Investing Cash Flow | -$388.8M | +10.7% |
| Financing Cash Flow | $623.2M | +47.1% |
| Free Cash Flow | -$297.1M | -57.2% |